President/CEO
John Bierman
John studied economics at Rutgers University and Montclair State University. John was an NCAA student-athlete and Professional racquetball player. In 1983, at 23 years old, John started SkyHi Building Services Corporation. 38 years later he continues to run and oversee the day to day operations. Over the past 38 years he has provided employment opportunities for thousands of people in the tri-state area.
Chief Business Development Officer
Sean Bierman
Sean studied human/organizational development and business management at Vanderbilt University and The University of Tampa. After completing his studies, Sean spent the next five years playing professional baseball for four major league organizations. He is one of the original personnel that built the framework for Advanced Electrostatic Disinfecting in 2016. Sean is also the founder of a baseball training facility and amateur baseball organization in Northern New Jersey.
Vice President of Sales
Matt Conrad
Matt is a New Jersey native and current resident of the state. He attended The College of New Jersey and started his career with Teach For America, helping underprivileged students learn to read in Miami, Florida. For the past seven years, Matt has led Enterprise Sales Teams at IBM, and partnered with C-Suite level clients at Colgate- Palmolive, Tiffany & Co. and Campbell Soup among others.
Public Health Advisor
Andrew Goulian
Andrew completed both his undergraduate degree in neuroscience and a
master’s degree in public health at Columbia University in New York City. He has worked as both a neuroscience and public health researcher in a variety of applications including biochemical analysis and clinical trials.
Andrew is at the forefront of the developing public health trends and initiatives. He serves as our advisor for occurring trends, as well as product and delivery applications.
master’s degree in public health at Columbia University in New York City. He has worked as both a neuroscience and public health researcher in a variety of applications including biochemical analysis and clinical trials.
Andrew is at the forefront of the developing public health trends and initiatives. He serves as our advisor for occurring trends, as well as product and delivery applications.